Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as lowering the risks of heart and kidney problems.
News24 | Which of the breakthrough weight-loss medicines can you get in SA?
By staff1 Min Read
Keep Reading
© 2025 Times Network. All Rights Reserved.